Statera Biopharma, Inc. STAB
Regular-session close
- YTD
- -66.67%
- 1 year
- 0.00%
STAB free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-28,376,253 USD
FY 2021 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | -28,376,253 | -23,284,472 | Not meaningful |
| FY 2020 | 2020-12-31 | -5,091,781 | Not available | Not available |
| FY 2019 | 2019-12-31 | Not available | Not available | Not available |
| FY 2018 | 2018-12-31 | Not available | Not available | Not available |
| FY 2017 | 2017-12-31 | Not available | Not available | Not available |
| FY 2016 | 2016-12-31 | Not available | Not available | Not available |
| FY 2015 | 2015-12-31 | Not available | Not available | Not available |
| FY 2014 | 2014-12-31 | -14,475,410 | 8,766,728 | Not meaningful |
| FY 2013 | 2013-12-31 | -23,242,138 | -2,414,364 | Not meaningful |
| FY 2012 | 2012-12-31 | -20,827,774 | -3,266,831 | Not meaningful |
| FY 2011 | 2011-12-31 | -17,560,943 | -11,195,962 | Not meaningful |
| FY 2010 | 2010-12-31 | -6,364,981 | -1,983,637 | Not meaningful |
| FY 2009 | 2009-12-31 | -4,381,344 | 7,964,171 | Not meaningful |
| FY 2008 | 2008-12-31 | -12,345,515 | 5,248,756 | Not meaningful |
| FY 2007 | 2007-12-31 | -17,594,271 | -10,753,009 | Not meaningful |
| FY 2006 | 2006-12-31 | -6,841,262 | -4,781,993 | Not meaningful |
| FY 2005 | 2005-12-31 | -2,059,269 | -1,823,367 | Not meaningful |
| FY 2004 | 2004-12-31 | -235,902 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:59.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
